Skip to main content
Top
Published in: Cardiovascular Intervention and Therapeutics 2/2021

01-04-2021 | Aortic Valve Replacement | Images in Cardiovascular Intervention

Combining the CoreValve Evolut PRO and 14-French eSheath in transfemoral transcatheter aortic valve replacement

Authors: Masaki Yashige, Kan Zen, Yoshito Kadoya, Satoaki Matoba

Published in: Cardiovascular Intervention and Therapeutics | Issue 2/2021

Login to get access

Abstract

Despite the small profile, it is occasionally difficult to pass the CoreValve InLine sheath through a calcified or tortuous femoral access. We present the case of an 84-year-old woman with a symptomatic severe aortic stenosis, wherein transfemoral transcatheter aortic valve replacement (TAVR) was performed using a self-expandable CoreValve Evolut PRO. Although delivering the CoreValve InLine sheath was difficult due to iliac artery calcification, a low-profile 14-French expandable eSheath proved useful for delivering the Evolut PRO system. This case demonstrated the feasibility of using the Evolut PRO valve combined with a 14-French eSheath, which was designed for the Edwards SAPIEN valve.
Literature
1.
go back to reference Koehler T, Buege M, Schleiting H, Seyfarth M, Tiroch K, Vorpahl M. Changes of the eSheath outer dimensions used for transfemoral transcatheter aortic valve replacement. Biomed Res Int. 2015;2015:572681.CrossRef Koehler T, Buege M, Schleiting H, Seyfarth M, Tiroch K, Vorpahl M. Changes of the eSheath outer dimensions used for transfemoral transcatheter aortic valve replacement. Biomed Res Int. 2015;2015:572681.CrossRef
Metadata
Title
Combining the CoreValve Evolut PRO and 14-French eSheath in transfemoral transcatheter aortic valve replacement
Authors
Masaki Yashige
Kan Zen
Yoshito Kadoya
Satoaki Matoba
Publication date
01-04-2021
Publisher
Springer Singapore
Published in
Cardiovascular Intervention and Therapeutics / Issue 2/2021
Print ISSN: 1868-4300
Electronic ISSN: 1868-4297
DOI
https://doi.org/10.1007/s12928-020-00659-1

Other articles of this Issue 2/2021

Cardiovascular Intervention and Therapeutics 2/2021 Go to the issue